3 Aug 2020
EUR 60 million
Industries and services
NIB and the Danish hearing healthcare company Demant A/S have signed a new loan agreement of DKK 450 million (EUR 60 million) to finance the company’s research investments for 2019.
The seven-year loan finances in part Demant’s current R&D programme, which focuses on the development of new audiological technology and on improving the design, computational powers and longevity of hearing aid devices to improve user experiences.
Global demand for hearing aids is increasing due to demographic change and better diagnostics.
Demant is working in close cooperation with universities, research centres and the corporate sector to advance hearing healthcare technology. The company has its own research facility, Eriksholm, dedicated to pursuing audiological innovations.
This is the third loan agreed between NIB and Demant since 2015.
Demant A/S is a Denmark-based global leader in modern hearing healthcare solutions. The company’s product range includes hearing aids, diagnostic instruments, hearing implants and audio solutions in areas such as enterprise communication and gaming.
NIB is an international financial institution owned by eight member countries: Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway and Sweden. The Bank finances private and public projects in and outside the member countries. NIB has the highest possible credit rating, AAA/Aaa, with the leading rating agencies Standard & Poor’s and Moody’s.
For further information, please contact
Mr Vagn Lundhøj, Senior Manager, Origination, at +358 10 618 0370, email@example.com
Ms Lisa-Maria Altenberger, Communications Unit, at +358 10 618 0234, firstname.lastname@example.org